Optimizing doxepin therapy in dermatology: introducing blood level monitoring and genotype testing.

Abstract excerpt

Doxepin, a tricyclic antidepressant, is the most efficacious antipruritic available to dermatologists; however its use is often suboptimal because of significant interindividual variability in doxepin plasma levels and clinical response between patients taking the same dose. As result, the Food and Drug Administration approves a maximum dose of 300 mg of doxepin per day and a 10 mg per cc liquid doxepin...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Genotype
• Share to Treatment Failure